SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-164068
Filing Date
2013-04-22
Accepted
2013-04-22 09:01:20
Documents
4
Period of Report
2013-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d526054d8k.htm 8-K 20831
2 EX-10.1 d526054dex101.htm EX-10.1 128736
3 EX-99.1 d526054dex991.htm EX-99.1 10133
4 GRAPHIC g526054g43s02.jpg GRAPHIC 26817
  Complete submission text file 0001193125-13-164068.txt   198109
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 13772775
SIC: 2835 In Vitro & In Vivo Diagnostic Substances